Clinical Study to Generate a Set of Data Characterising Clinical Events, Physiological Responses, and Innate and Adaptive Immune Responses Following a Single IM Immunisation With Fluad Seasonal Influenza Vaccine or Placebo in Healthy Adults
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2019
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 Jun 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 06 Jun 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.